Description
IGF::OT::IGF RADIOPHARMACEUTICALS - INCREASE FUNDS TO COVER LATE INVOICING
Base award description: IGF::OT::IGF RADIOPHARMACEUTICALS
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-01-01+$82,437= $82,437
- Mod P000012014-11-20-$30,890= $51,547
- Mod P000022015-02-25+$4,885= $56,432
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-01-01 | +$82,437 | $82,437 | IGF::OT::IGF RADIOPHARMACEUTICALS |
| Mod P00001· CLOSE OUT | 2014-11-20 | −$30,890 | $51,547 | IGF::OT::IGF RADIOPHARMACEUTICALS - DECREASE EXCESS FUNDS |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2015-02-25 | +$4,885 | $56,432 | IGF::OT::IGF RADIOPHARMACEUTICALS - INCREASE FUNDS TO COVER LATE INVOICING |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI LM6RSRTLHTE6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24526N0078 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $70,190 | FY2026 |
| 36C24525N0077 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $60,624 | FY2025 |
| 36C24524F0346 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $22,914 | FY2024 |
| 36C24524D0027 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| 36C24224N0086 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $169,179 | FY2024 |
| 36C24223N0048 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $635,965 | FY2023 |
Other recipients under 6505 from 246-NETWORK CONTRACTING OFFICE 6 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24616J4018 | SANOFI VACCINES US INC. | 246-NETWORK CONTRACTING OFFICE 6 | $28,335 | FY2016 |
| VA24616F4029 | ACTELION PHARMACEUTICALS US, INC. | 246-NETWORK CONTRACTING OFFICE 6 | $4,874 | FY2016 |
| VA24616J0011 | GLAXOSMITHKLINE, LLC | 246-NETWORK CONTRACTING OFFICE 6 | $6,390 | FY2016 |
| VA24616J3895 | SANOFI VACCINES US INC. | 246-NETWORK CONTRACTING OFFICE 6 | $8,501 | FY2016 |
| VA24616J3970 | SANOFI VACCINES US INC. | 246-NETWORK CONTRACTING OFFICE 6 | $141,675 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24614J1702_3600_VA24614D0077_3600 · retrieved 2026-09-26.